FORM 10-Q
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE | |
| SECURITIES EXCHANGE ACT OF 1934 | ||
| For the quarterly period ended SEPTEMBER 30, 2004 | ||
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE | |
| SECURITIES EXCHANGE ACT OF 1934 | ||
| For the transition period from to | ||
| Commission file number 1-10816 |
MGIC INVESTMENT CORPORATION
| WISCONSIN (State or other jurisdiction of incorporation or organization) |
39-1486475 (I.R.S. Employer Identification No.) |
|
| 250 E. KILBOURN AVENUE MILWAUKEE, WISCONSIN (Address of principal executive offices) |
53202 (Zip Code) |
(414) 347-6480
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES [X]
|
NO [ ] |
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).
YES [X]
|
NO [ ] |
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
| CLASS OF STOCK |
PAR VALUE |
DATE |
NUMBER OF SHARES |
|||||||||
Common stock |
$ | 1.00 | 10/31/04 | 96,779,464 | ||||||||
Page 1
MGIC INVESTMENT CORPORATION
TABLE OF CONTENTS
| Page No. |
||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6-12 | ||||||||
| 13-33 | ||||||||
| 33 | ||||||||
| 33 | ||||||||
| 34 | ||||||||
| 35 | ||||||||
| 35 | ||||||||
| 36 | ||||||||
| 37 | ||||||||
| Amended and Restated Bylaws | ||||||||
| Statement Re Computation of Net Income Per Share | ||||||||
| 302 Certification of CEO | ||||||||
| 302 Certification of CFO | ||||||||
| 906 Certification of CEO and CFO | ||||||||
Page 2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
MGIC INVESTMENT CORPORATION AND SUBSIDIARIES
| September 30, | December 31, | |||||||
| 2004 |
2003 |
|||||||
| (In thousands of dollars) | ||||||||
ASSETS |
||||||||
Investment portfolio: |
||||||||
Securities, available-for-sale, at market value: |
||||||||
Fixed maturities |
$ | 5,296,831 | $ | 5,059,147 | ||||
Equity securities |
5,399 | 8,280 | ||||||
Short-term investments |
273,137 | 137,734 | ||||||
Total investment portfolio |
5,575,367 | 5,205,161 | ||||||
Cash |
2,820 | 23,612 | ||||||
Accrued investment income |
62,075 | 59,588 | ||||||
Reinsurance recoverable on loss reserves |
17,379 | 18,074 | ||||||
Prepaid reinsurance premiums |
7,173 | 7,528 | ||||||
Premiums receivable |
94,413 | 122,290 | ||||||
Home office and equipment, net |
35,742 | 36,722 | ||||||
Deferred insurance policy acquisition costs |
29,298 | 32,613 | ||||||
Investments in joint ventures |
362,427 | 308,213 | ||||||
Other assets |
112,650 | 103,586 | ||||||
Total assets |
$ | 6,299,344 | $ | 5,917,387 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Liabilities: |
||||||||
Loss reserves |
$ | 1,150,610 | $ | 1,061,788 | ||||
Unearned premiums |
139,903 | 168,137 | ||||||
Short- and long-term debt (note 2) |
599,726 | 599,680 | ||||||
Income taxes payable |
106,144 | 118,126 | ||||||
Other liabilities |
177,074 | 172,754 | ||||||
Total liabilities |
2,173,457 | 2,120,485 | ||||||
Contingencies (note 3) |
||||||||
Shareholders equity: |
||||||||
Common stock, $1 par value, shares authorized
|
||||||||
300,000,000; shares issued, 9/30/04 - 122,318,945
12/31/03 - 121,587,417;
|
||||||||
shares outstanding, 9/30/04 - 97,946,864
12/31/03 - 98,412,844 |
122,319 | 121,587 | ||||||
Paid-in capital |
267,469 | 239,485 | ||||||
Treasury stock (shares at cost, 9/30/04 - 24,372,081
12/31/03 - 23,174,573) |
(1,204,255 | ) | (1,115,969 | ) | ||||
Accumulated other comprehensive income, net of tax |
125,313 | 140,651 | ||||||
Retained earnings |
4,815,041 | 4,411,148 | ||||||
Total shareholders equity |
4,125,887 | 3,796,902 | ||||||
Total liabilities and shareholders equity |
$ | 6,299,344 | $ | 5,917,387 | ||||
See accompanying notes to consolidated financial statements.
Page 3
MGIC INVESTMENT CORPORATION AND SUBSIDIARIES
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, |
September 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (In thousands of dollars, except per share data) | ||||||||||||||||
Revenues: |
||||||||||||||||
Premiums written: |
||||||||||||||||
Direct |
$ | 351,424 | $ | 375,707 | $ | 1,057,855 | $ | 1,097,665 | ||||||||
Assumed |
99 | 35 | 161 | 77 | ||||||||||||
Ceded |
(30,720 | ) | (29,130 | ) | (89,025 | ) | (89,042 | ) | ||||||||
Net premiums written |
320,803 | 346,612 | 968,991 | 1,008,700 | ||||||||||||
Decrease (increase) in unearned premiums, net |
3,421 | (7 | ) | 27,877 | 7,196 | |||||||||||
Net premiums earned |
324,224 | 346,605 | 996,868 | 1,015,896 | ||||||||||||
Investment income, net of expenses |
54,187 | 50,049 | 159,642 | 151,446 | ||||||||||||
Realized investment gains (losses), net |
(228 | ) | 6,740 | 15,025 | 33,375 | |||||||||||
Other revenue |
12,851 | 23,987 | 38,087 | 67,247 | ||||||||||||
Total revenues |
391,034 | 427,381 | 1,209,622 | 1,267,964 | ||||||||||||
Losses and expenses: |
||||||||||||||||
Losses incurred, net |
169,802 | 220,726 | 514,552 | 536,057 | ||||||||||||
Underwriting and other expenses, net |
68,782 | 76,800 | 208,819 | 230,304 | ||||||||||||
Interest expense |
10,310 | 10,191 | 30,760 | 30,892 | ||||||||||||
Total losses and expenses |
248,894 | 307,717 | 754,131 | 797,253 | ||||||||||||
Income before tax and joint ventures |
142,140 | 119,664 | 455,491 | 470,711 | ||||||||||||
Provision for income tax |
37,649 | 27,504 | 124,210 | 122,948 | ||||||||||||
Income from joint ventures, net of tax |
29,578 | 12,969 | 87,385 | 42,253 | ||||||||||||
Net income |
$ | 134,069 | $ | 105,129 | $ | 418,666 | $ | 390,016 | ||||||||
Earnings per share (note 4): |
||||||||||||||||
Basic |
$ | 1.37 | $ | 1.07 | $ | 4.27 | $ | 3.94 | ||||||||
Diluted |
$ | 1.36 | $ | 1.06 | $ | 4.25 | $ | 3.94 | ||||||||
Weighted average common shares
outstanding - diluted (shares in
thousands, note 4) |
98,386 | 98,825 | 98,578 | 99,083 | ||||||||||||
Dividends per share |
$ | 0.075 | $ | 0.025 | $ | 0.150 | $ | 0.075 | ||||||||
See accompanying notes to consolidated financial statements.
Page 4
MGIC INVESTMENT CORPORATION AND SUBSIDIARIES
| Nine Months Ended | ||||||||
| September 30, |
||||||||
| 2004 |
2003 |
|||||||
| (In thousands of dollars) | ||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 418,666 | $ | 390,016 | ||||
Adjustments to reconcile net income to net cash
provided by operating activities: |
||||||||
Amortization of deferred insurance policy
acquisition costs |
18,319 | 21,495 | ||||||
Increase in deferred insurance policy
acquisition costs |
(15,004 | ) | (23,359 | ) | ||||
Depreciation and amortization |
16,114 | 15,820 | ||||||
(Increase) decrease in accrued investment income |
(2,487 | ) | 1,456 | |||||
Decrease in reinsurance recoverable on loss reserves |
695 | 2,315 | ||||||
Decrease in prepaid reinsurance premiums |
355 | 723 | ||||||
Decrease (increase) in premium receivable |
27,877 | (10,037 | ) | |||||
Increase in loss reserves |
88,822 | 223,360 | ||||||
Decrease in unearned premiums |
(28,234 | ) | (7,919 | ) | ||||
Decrease in income taxes payable |
(11,982 | ) | (12,689 | ) | ||||
Equity earnings in joint ventures |
(127,391 | ) | (60,125 | ) | ||||
Distributions from joint ventures |
82,300 | 19,950 | ||||||
Other |
(2,269 | ) | (25,290 | ) | ||||
Net cash provided by operating activities |
465,781 | 535,716 | ||||||
Cash flows from investing activities: |
||||||||
Purchase of equity securities |
(127 | ) | | |||||
Purchase of fixed maturities |
(1,505,861 | ) | (2,339,236 | ) | ||||
Additional investment in joint ventures |
(8,458 | ) | (7,793 | ) | ||||
Sale of investment in joint ventures |
| 3,396 | ||||||
Sale of equity securities |
4,962 | 4,133 | ||||||
Proceeds from sale or maturity of fixed maturities |
1,238,167 | 2,078,154 | ||||||
Net cash used in investing activities |
(271,317 | ) | (261,346 | ) | ||||
Cash flows from financing activities: |
||||||||
Dividends paid to shareholders |
(14,773 | ) | (7,433 | ) | ||||
Net repayment of short-term debt |
(1,059 | ) | (73,537 | ) | ||||
Reissuance of treasury stock |
2,588 | 335 | ||||||
Repurchase of common stock |
(95,744 | ) | (89,192 | ) | ||||
Common stock issued |
29,135 | 4,802 | ||||||
Net cash used in financing activities |
(79,853 | ) | (165,025 | ) | ||||
Net increase in cash and short-term investments |
114,611 | 109,345 | ||||||
Cash and short-term investments at beginning of period |
161,346 | 113,271 | ||||||
Cash and short-term investments at end of period |
$ | 275,957 | $ | 222,616 | ||||
See accompanying notes to consolidated financial statements.
Page 5
MGIC INVESTMENT CORPORATION AND SUBSIDIARIES
Note 1 - Basis of presentation and summary of certain significant accounting policies
The accompanying unaudited consolidated financial statements of MGIC Investment Corporation (the Company) and its wholly-owned subsidiaries have been prepared in accordance with the instructions to Form 10-Q and do not include all of the other information and disclosures required by accounting principles generally accepted in the United States of America. These statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2003 included in the Companys Annual Report on Form 10-K for that year.
The accompanying consolidated financial statements have not been audited by independent auditors in accordance with the standards of the Public Company Accounting Oversight Board (United States), but in the opinion of management such financial statements include all adjustments, consisting only of normal recurring accruals, necessary to summarize fairly the Companys financial position and results of operations. The results of operations for the nine months ended September 30, 2004 may not be indicative of the results that may be expected for the year ending December 31, 2004.
Stock-based compensation
The Company has certain stock-based compensation plans. Effective January 1, 2003, the Company adopted the fair value recognition provisions of SFAS No. 123, Accounting for Stock-Based Compensation, prospectively to all employee awards granted or modified on or after January 1, 2003. The adoption of SFAS No. 123 did not have a material effect on the Companys results of operations or its financial position. Under the fair value method, compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period which generally corresponds to the vesting period. Awards under the Companys plans generally vest over periods ranging from one to five years. The cost related to stock-based employee compensation included in the determination of net income for 2004 and 2003 is less than that which would have been recognized if the fair value based method had been applied to all awards since the original effective date of SFAS No. 123. The following table illustrates the effect on net income and earnings per share if the fair value method had been applied to all outstanding and unvested awards in each period.
Page 6
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, |
September 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (in thousands of dollars, except per share data) | ||||||||||||||||
Net income, as reported |
$ | 134,069 | $ | 105,129 | $ | 418,666 | $ | 390,016 | ||||||||
Add stock-based employee compensation
expense included in reported net income,
net of tax |
1,903 | 1,058 | 5,648 | 3,088 | ||||||||||||
Deduct stock-based employee compensation
expense determined under fair value method
for all awards, net of tax |
(3,021 | ) | (2,581 | ) | (8,556 | ) | (7,923 | ) | ||||||||
Pro forma net income |
$ | 132,951 | $ | 103,606 | $ | 415,758 | $ | 385,181 | ||||||||
Earnings per share: |
||||||||||||||||
Basic, as reported |
$ | 1.37 | $ | 1.07 | $ | 4.27 | $ | 3.94 | ||||||||
Basic, pro forma |
$ | 1.36 | $ | 1.05 | $ | 4.24 | $ | 3.90 | ||||||||
Diluted, as reported |
$ | 1.36 | $ | 1.06 | $ | 4.25 | $ | 3.94 | ||||||||
Diluted, pro-forma |
$ | 1.35 | $ | 1.05 | $ | 4.22 | $ | 3.89 | ||||||||
New Accounting Standards
The guidance contained in EITF 03-1 has been delayed by FSP EITF 03-1-1, Effective Date of Paragraphs 10-20 of EITF Issue No. 03-1 The meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments"'. The delay of the effective date will be superseded with the final issuance of proposed FSP EITF Issue 03-1-a, Implication Guidance for the Application of Paragraph 16 of EITF Issue No. 03-1 which was subject to comments through October 29, 2004. The disclosures continue to be effective in annual financial statements for fiscal years ending after December 15, 2003, for investments accounted for under Statements 115 and 124. The impact of FSP EITF 03-1-a on the Companys financial position or results of operations cannot be determined at this time. Under the proposed guidance, it may be more likely that a decrease in the market value of certain investments in the Companys fixed income portfolio will be required to be recognized as a realized loss in the statement of operations than under the existing accounting standard.
Note 2 - Short- and long-term debt
The Company has a $285 million commercial paper program, which is rated A-1 by Standard and Poors (S&P) and P-1 by Moodys. At September 30, 2004 and 2003, the Company had $100.0 million and $105.0 million in commercial paper outstanding with a weighted average interest rate of 1.83% and 1.15%, respectively.
Page 7
The Company had a $285 million credit facility available at September 30, 2004, expiring in 2006. Under the terms of the credit facility, the Company must maintain shareholders equity of at least $2.25 billion and Mortgage Guaranty Insurance Corporation (MGIC) must maintain a risk-to-capital ratio of not more than 22:1 and maintain policyholders position (which includes MGICs statutory surplus and its contingency reserve) of not less than the amount required by Wisconsin insurance regulation. At September 30, 2004, the Company met these requirements. The facility is currently being used as a liquidity back up facility for the outstanding commercial paper. The remaining credit available under the facility after reduction for the amount necessary to support the commercial paper was $185.0 million at September 30, 2004.
The Company had $300 million, 7.5% Senior Notes due in 2005 and $200 million, 6% Senior Notes due in 2007 outstanding at September 30, 2004 and 2003. At September 30, 2004 and 2003, the market value of the outstanding debt was $626.9 million and $648.2 million, respectively.
Interest payments on all long-term and short-term debt were $28.8 million for both the nine months ended September 30, 2004 and 2003.
In May 2002, a swap designated as a cash flow hedge was amended to coincide with the credit facility. Under the terms of the swap contract, the Company pays a fixed rate of 5.43% and receives an interest rate based on LIBOR. The swap has an expiration date coinciding with the maturity of the credit facility and is designated as a cash flow hedge. The cash flow swap outstanding at September 30, 2004 and 2003 is evaluated quarterly using regression analysis with any ineffectiveness being recorded as an expense. To date this evaluation has not resulted in any hedge ineffectiveness. Swaps are subject to credit risk to the extent the counterparty would be unable to discharge its obligations under the swap agreements.
Expense on the interest rate swaps for the nine months ended September 30, 2004 and 2003 of approximately $2.7 million and $2.5 million, respectively, was included in interest expense. Gains or losses arising from the amendment or termination of previously held interest rate swaps are deferred and amortized to interest expense over the life of the hedged items.
Note 3 - Litigation and contingencies
The Company is involved in litigation in the ordinary course of business. In the opinion of management, the ultimate resolution of this pending litigation will not have a material adverse effect on the financial position or results of operations of the Company.
In addition, in March 2003 an action against MGIC was filed in Federal District Court in Orlando, Florida seeking certification of a nationwide class of consumers who were required to pay for private mortgage insurance written by MGIC and whose loans were insured at less than MGICs best available rate based on credit scores obtained by MGIC. (A portion of MGICs A minus and subprime premium rates are based in part on the credit score of the borrower.) The action alleges that the Federal Fair Credit Reporting Act (FCRA) requires a notice to borrowers of such adverse action and that MGIC has violated FCRA by failing to give such notice. The action seeks statutory
Page 8
damages (which in the case of willful violations, in addition to punitive damages, may be awarded in an amount of $100 to $1,000 per class member) and/or actual damages of the persons in the class, and attorneys fees, as well as declaratory and injunctive relief. The action also alleges that the failure to give notice to borrowers in Florida in the circumstances alleged is a violation of Floridas Unfair and Deceptive Acts and Practices Act and seeks declaratory and injunctive relief for such violation. In December 2003, the Court denied MGICs motion seeking dismissal of the portion of the case covering damages under FCRA but dismissed the remainder of the case. In June 2004, the Court denied the plaintiffs motion to certify the class. There can be no assurance that the outcome of the litigation will not materially affect the Companys financial position or results of operations. Similar actions are pending against six other mortgage insurers.
Under its contract underwriting agreements, the Company may be required to provide certain remedies to its customers if certain standards relating to the quality of the Companys underwriting work are not met. The cost of remedies provided by the Company to customers for failing to meet these standards has not been material to the Companys financial position or results of operations for the nine months ended September 30, 2004 and 2003.
Note 4 - Earnings per share
The Companys basic and diluted earnings per share (EPS) have been calculated in accordance with SFAS No. 128, Earnings Per Share. The Companys net income is the same for both basic and diluted EPS. Basic EPS is based on the weighted average number of common shares outstanding. Diluted EPS is based on the weighted average number of common shares outstanding plus common stock equivalents which include stock awards and stock options. The following is a reconciliation of the weighted average number of shares used for basic EPS and diluted EPS.
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, |
September 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (Shares in thousands) | ||||||||||||||||
Weighted average shares - Basic |
97,760 | 98,489 | 97,987 | 98,879 | ||||||||||||
Common stock equivalents |
626 | 336 | 591 | 204 | ||||||||||||
Weighted average shares - Diluted |
98,386 | 98,825 | 98,578 | 99,083 | ||||||||||||
Page 9
Note 5 - Comprehensive income
The Companys total comprehensive income, as calculated per SFAS No. 130, Reporting Comprehensive Income, was as follows:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, |
September 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (In thousands of dollars) | ||||||||||||||||
Net income |
$ | 134,069 | $ | 105,129 | $ | 418,666 | 390,016 | |||||||||
Other comprehensive income (loss) |
86,815 | (37,449 | ) | (15,338 | ) | (9,859 | ) | |||||||||
Total comprehensive income |
$ | 220,884 | $ | 67,680 | $ | 403,328 | 380,157 | |||||||||
Other comprehensive income (loss) (net of tax): |
||||||||||||||||
Net derivative gains |
$ | 190 | $ | 908 | $ | 1,928 | $ | 494 | ||||||||
Amortization of deferred losses |
270 | 270 | 810 | 810 | ||||||||||||
Change in unrealized gains and losses
on investments |
86,949 | (38,627 | ) | (18,427 | ) | (11,163 | ) | |||||||||
Other |
(594 | ) | | 351 | | |||||||||||
Other comprehensive income (loss) |
$ | 86,815 | $ | (37,449 | ) | $ | (15,338 | ) | $ | (9,859 | ) | |||||
The difference between the Companys net income and total comprehensive income for the three and nine months ended September 30, 2004 and 2003 is due to the change in unrealized appreciation/depreciation on investments, the fair value adjustment and amortization of deferred losses relating to derivative financial instruments and the Companys share of the other comprehensive income/loss on one of its joint venture investments, all net of tax.
Page 10
Note 6 - Benefit Plans
The following table provides the components of net periodic benefit cost for the pension and other postretirement benefit plans:
| Three Months Ended | ||||||||||||||||
| September 30, |
||||||||||||||||
| Other Postretirement | ||||||||||||||||
| Pension Benefits |
Benefits |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (In thousands of dollars) | ||||||||||||||||
Service cost |
$ | 2,285 | $ | 1,991 | $ | 865 | $ | 784 | ||||||||
Interest cost |
2,185 | 1,918 | 881 | 825 | ||||||||||||
Expected return on plan assets |
(2,592 | ) | (1,699 | ) | (430 | ) | (247 | ) | ||||||||
Recognized net actuarial loss (gain) |
311 | 487 | 125 | 165 | ||||||||||||
Amortization of transition obligation |
| | 132 | 132 | ||||||||||||
Amortization of prior service cost |
175 | 153 | | | ||||||||||||
Net periodic benefit cost |
$ | 2,364 | $ | 2,850 | $ | 1,573 | $ | 1,659 | ||||||||
| Nine Months Ended | ||||||||||||||||
| September 30, |
||||||||||||||||
| Other Postretirement | ||||||||||||||||
| Pension Benefits |
Benefits |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (In thousands of dollars) | ||||||||||||||||
Service cost |
$ | 6,855 | $ | 5,973 | $ | 2,595 | $ | 2,352 | ||||||||
Interest cost |
6,555 | 5,754 | 2,643 | 2,475 | ||||||||||||
Expected return on plan assets |
(7,776 | ) | (5,097 | ) | (1,290 | ) | (741 | ) | ||||||||
Recognized net actuarial loss (gain) |
933 | 1,461 | 375 | 495 | ||||||||||||
Amortization of transition obligation |
| | 396 | 396 | ||||||||||||
Amortization of prior service cost |
525 | 459 | | | ||||||||||||
Net periodic benefit cost |
$ | 7,092 | $ | 8,550 | $ | 4,719 | $ | 4,977 | ||||||||
Through the nine months ended September 30, 2004 the Company has contributed $10.0 million to its pension plan. The Company expects to contribute an additional $13.7 million to the plan in the fourth quarter of 2004.
On December 8, 2003 the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (Act) was signed into law. The Act introduces a prescription drug benefit under Medicare Part D as well as a federal subsidy to sponsors of the retiree health care benefit plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. Beginning in the second quarter of 2004, the effects of the subsidy are reflected in the measurement of the net periodic postretirement benefit costs. The effect of the subsidy on the measurement of the annual net periodic postretirement benefit cost
Page 11
for the current year was a $1.4 million reduction, of which 50% ($0.7 million) was recognized in the second quarter. The components of the $1.4 million reduction include $0.5 million related to service cost, $0.5 million related to interest cost and $0.4 million related to recognized net actuarial gain/loss. The effect of the subsidy on the Accumulated Postretirement Benefit Obligation was a $7.5 million reduction.
Page 12
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
Business and General Environment
The Company, through its subsidiary Mortgage Guaranty Insurance Corporation (MGIC), is the leading provider of private mortgage insurance in the United States to the home mortgage lending industry. The Companys principal products are primary mortgage insurance and pool mortgage insurance. Primary mortgage insurance may be written on a flow basis, in which loans are insured in individual, loan-by-loan transactions, or may be written on a bulk basis, in which a portfolio of loans is individually insured in a single, bulk transaction.
The Companys results of operations are affected by:
| | Premiums written and earned |